Experienced in Metabolic Acidosis

Yaling F. Han

83 Wenhua Road, 
Shenyang, CN 
Experienced in Metabolic Acidosis
83 Wenhua Road, 
Shenyang, CN 
OverviewLocationsClinical Research

Overview

Yaling Han practices in Shenyang, China. Han is rated as an Experienced expert by MediFind in the treatment of Metabolic Acidosis. Their top areas of expertise are Heart Attack, Acute Coronary Syndrome, Coronary Heart Disease, Percutaneous Coronary Intervention (PCI), and Angioplasty.

Their clinical research consists of co-authoring 575 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Metabolic Acidosis.

Locations

83 Wenhua Road, Shenyang, 110016, China
Other Locations
No. 218 Ziqiang Street, Changchun, China
Chinese People's Liberation Army No. 83 Wenhua Road, Shenyang, 100840, China
150#Jimo Road, Pudong, 200120, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase III, Randomized, Double-blind, Placebo-controlled Clinical Study Evaluating the Efficacy and Safety of JS002 in Patients With Primary Hypercholesterolemia and Mixed Hyperlipidemia in China
A Phase III, Randomized, Double-blind, Placebo-controlled Clinical Study Evaluating the Efficacy and Safety of JS002 in Patients With Primary Hypercholesterolemia and Mixed Hyperlipidemia in China
Enrollment Status: Completed
Publish Date: April 19, 2023
Intervention Type: Drug
Study Drug: JS002
Study Phase: Phase 3
A Randomized Trial of a Biolimus-Coated Balloon Versus POBA in Small Vessel Coronary Artery Disease
A Randomized Trial of a Biolimus-Coated Balloon Versus POBA in Small Vessel Coronary Artery Disease
Enrollment Status: Completed
Publish Date: September 22, 2021
Intervention Type: Device
Study Phase: Not Applicable
The Efficacy, Safety and Pharmacokinetic of Antiplatelet Therapy for Vicagrel in Patients With Coronary Atherosclerotic Heart Disease and Planned Percutaneous Coronary Intervention: a Multi-center, Randomized, Double-blind, Triple-dummy , Parallel-controlled, Dose-exploration Phase II Trial
The Efficacy, Safety and Pharmacokinetic of Antiplatelet Therapy for Vicagrel in Patients With Coronary Atherosclerotic Heart Disease and Planned Percutaneous Coronary Intervention: a Multi-center, Randomized, Double-blind, Triple-dummy , Parallel-controlled, Dose-exploration Phase II Trial
Enrollment Status: Completed
Publish Date: September 23, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 2 Less Clinical Trials

573 Total Publications

Correction to: miR-3154: Novel Pathogenic and Therapeutic Target in Abdominal Aortic Aneurysm.
Correction to: miR-3154: Novel Pathogenic and Therapeutic Target in Abdominal Aortic Aneurysm.
Journal: Circulation research
Published: January 02, 2026

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Han's expertise for a condition
ConditionClose
View All 10 Advanced Conditions
View All 63 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile